Delivery Order HHSN268201100007I-HHSN26800002
- Not listed
- Vitalant Research Institute has been awarded a delivery order against the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute's Recipient Epidemiology and Donor Evaluation Study III (REDS-III) International Sites contract vehicle. This $716,542 cost-no-fee contract will support the REDS-III Phase 3 effort in Brazil. As the prime contractor, Vitalant VRI will leverage its expertise in blood donation and transfusion research to provide...
- This is a $2,206,818.78 delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Vitalant (formerly Blood Systems), a nonprofit organization, to conduct clinical and epidemiological research on transfusion safety concerns as part of the REDS-IV-P Brazil Phase 1 program. The contract does not have a set-aside designation. Vitalant's research division, the Vitalant Research Institute (VRI), is the prime contractor. VRI has subcontracted with...
- The National Heart Lung and Blood Institute issued a delivery order to Vitalant Research Institute on July 1, 2024, with a ceiling value of $2,702,179, for the REDS-IV-P Brazil Hub program under a cost-no-fee pricing structure. The order is set for ultimate completion on December 31, 2026, and performance takes place in Scottsdale, AZ. Vitalant Research Institute is a non-profit division of Vitalant, the nation's largest independent blood services provider, specializing in blood collection,...
- This federal contract was awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Vitalant, a nonprofit organization that provides blood products and conducts research related to transfusion medicine. The contract, titled "REDS-III" (Recipient Epidemiology and Donor Evaluation Study - III), has a ceiling value of $8,847,513.18 and a period of performance ending on December 31, 2019. The contract does not have a set-aside...
- This is a $493,905.79 delivery order awarded by the Department of Health and Human Services' National Institutes of Health's National Heart Lung and Blood Institute to The Institute For Transfusion Medicine, doing business as Vitalant Research Institute (a division of the nonprofit organization Vitalant). The order is for the Recipient Epidemiology and Donor Evaluation Study III (REDS-III) - Phase 3 - Domestic Site and has a completion date of December 31, 2019. The contract type is Cost No...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded Vitalant Research Institute a $727,897 delivery order contract to support the Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Central Laboratory program. Under the cost-no-fee contract, Vitalant will provide laboratory services from its facilities in San Francisco, California through December 2019 to assist NIH's ongoing research efforts aimed at improving...
- The National Heart, Lung and Blood Institute issued a delivery order to Vitalant Research Institute on April 1, 2021, for the REDS-IV-P Brazil Transfusion Safety Research Program Phase 2, with a ceiling value of $4.284 million and ultimate completion date of March 31, 2025. This is a cost-no-fee delivery order under a single-award parent vehicle. Place of performance is Bethesda, Maryland. Under this order, Vitalant Research Institute has invoiced the government across three fiscal years: $267...
- This federal contract award, with an ID of 75N92019D00034|75N92024F00001, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the prime contractor Vitalant, a non-profit organization. The contract, valued at $2,104,121.00, is for the REDS-IV-P DOMESTIC HUBS project and does not have a set-aside designation. Vitalant Research Institute (VRI), the research arm of Vitalant, is the prime contractor. VRI has established itself as a key federal partner, providing...
- This is a federal contract award to Vitalant, a nonprofit blood services provider, by the National Heart, Lung, and Blood Institute (NHLBI) for the REDS-IV-P Center for Transfusion Laboratory Studies. The $2,160,438 contract, which does not have a set-aside designation, will support Vitalant's Vitalant Research Institute (VRI) in conducting research and providing laboratory services related to transfusion medicine, blood safety, and infectious diseases. VRI will collaborate with Kaiser...
- This is a $1,590,903.99 delivery order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI) within the Department of Health and Human Services (HHS) to the nonprofit organization Vitalant, doing business as Vitalant Research Institute (VRI). The contract is for the REDS-IV-P Domestic Hubs - Phase 1 project and does not have a set-aside designation. VRI, the research division of Vitalant, is serving as the prime contractor and is partnering with subcontractors including the...
- HHSN268201100007IIndefinite Delivery Contract
- HHSN268201100007I-HHSN26800002Delivery Order
This delivery order against the REDS-III contract was awarded by the National Heart, Lung and Blood Institute to Vitalant Research Institute to support the REDS-III - International program in Brazil. Valued at $5.69 million, the effort involves establishing a sickle cell disease patient cohort and evaluating transfusion strategies and risks in Brazil. Vitalant will oversee clinical protocol implementation and data analysis in partnership with the University of Sao Paulo and blood collection sites in four Brazilian cities. Major subcontractors include UCSF Benioff Children's Hospital Oakland and the Fundacao Faculdade de Medicina to administer research activities. The contract runs from March 2013 through December 2019 to advance the National Institutes of Health's understanding of blood safety and availability issues internationally under the Rare Diseases Clinical Research Network.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Brazil | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 10/12/17, 1:48 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00011 | Close Out | $0 | 12/20/23 | |
| P00010 | Change Order | ($311k) | 8/30/21 | |
| P00009 | Other Administrative Action | ($108k) | 7/31/20 | |
| P00008 | Change Order | $0 | 3/19/19 | |
| 7 | Other Administrative Action | ($111k) | 9/11/18 |